Investigation of therapeutic efficacy of docetaxel, cisplatin and S1 (DCS) chemotherapy for advanced or recurrent gastric cancer
Phase 1
Recruiting
- Conditions
- Advanced/Recurrent Gastric cancer
- Registration Number
- JPRN-UMIN000019972
- Lead Sponsor
- Teikyo University Chiba Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Inadequate renal and liver function
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical response after 1 month after completion of DCS chemotherapy
- Secondary Outcome Measures
Name Time Method Adverse effect and pathological response